Beyond ATRX: The heterogeneous basis of Alternative Lengthening of Telomeres in osteosarcoma
Authors:
Open Access
- 3 June 2026
- journal article
- Published by Elsevier in Cancer Genetics
- Vol. 306-307, 123-129
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Topoisomerase IIIα controls alternative lengthening of telomeresCell Reports, 2025
- Decoding the genetic puzzle: Mutations in key driver genes of pancreatic neuroendocrine tumorsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2025
- Oxidative guanine base damage plays a dual role in regulating productive ALT-associated homology-directed repairCell Reports, 2024
- Pediatric phase 2 trial of a WEE1 inhibitor, adavosertib (AZD1775), and irinotecan for relapsed neuroblastoma, medulloblastoma, and rhabdomyosarcomaCancer, 2023
- Extensive Proliferation of Human Cancer Cells with Ever-Shorter TelomeresCell Reports, 2017
- Topoisomerase II inhibition suppresses the proliferation of telomerase-negative cancersCellular and Molecular Life Sciences, 2014
- Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomasGenes, Chromosomes and Cancer, 2013
- Human Sarcomas Are Mosaic for Telomerase-Dependent and Telomerase-Independent Telomere Maintenance MechanismsThe American Journal of Pathology, 2013
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- Divergent patterns of telomere maintenance mechanisms among human sarcomas: Sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomasGenes, Chromosomes and Cancer, 2004